Acorda Therapeutics | ACOR - Stock


Acorda Therapeutics reported $18.55M in Stock for its fiscal quarter ending in December of 2021.



Stock Change Date
Acadia Pharmaceuticals USD 31.57M 3.1M Mar/2026
Agios Pharmaceuticals USD 35.09M 2.17M Mar/2026
ALKERMES USD 336.7M 140.08M Mar/2026
Amgen USD 6.19B 39M Mar/2026
Anika Therapeutics USD 22.84M 4.05M Mar/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Biogen USD 1.95B 219.1M Mar/2026
BioMarin Pharmaceutical USD 1.27B 25.66M Mar/2026
Cara Therapeutics USD 900K 0 Mar/2025
Cipla INR 61.6B 5.18B Sep/2025
Clal Biotechnology ILS 4.44M 0 Mar/2021
CSL USD 6.47B 327M Jun/2025
Gilead Sciences USD 1.91B 140M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Grifols EUR 3.56B 63.19M Dec/2024
Halozyme Therapeutics USD 155.47M 21.01M Mar/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 132.91M 841K Mar/2026
Ligand Pharmaceuticals USD 13.27M 4.14M Mar/2026
MannKind USD 49.17M 13.85M Mar/2026
Merck EUR 4.56B 52M Dec/2025
Moderna USD 146M 7M Mar/2026
Neurocrine Biosciences USD 64.5M 4.5M Mar/2026
Novartis USD 6.29B 17M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Sanofi EUR 22.69B 1.81B Dec/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
Ultragenyx Pharmaceutical USD 55M 3M Mar/2026
Vertex Pharmaceuticals USD 1.77B 79.9M Mar/2026